Behavioral control of the stressor modulates stress-induced changes in neurogenesis and fibroblast growth factor-2

被引:41
|
作者
Bland, ST
Schmid, MJ
Greenwood, BN
Watkins, LR
Maier, SF
机构
[1] Univ Colorado, Ctr Neurosci, Dept Psychol, Boulder, CO 80309 USA
[2] Univ Colorado, Ctr Neurosci, Dept Integrat Physiol, Boulder, CO 80309 USA
关键词
FGF-2; learned helplessness; neurogenesis; stress;
D O I
10.1097/00001756-200604240-00008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The controllability of stressors modulates many of the consequences of stressor exposure. Here, we used immunohistochemistry to examine neural progenitor cell proliferation and survival and basic fibroblast growth factor-2 in the hippocampus of male rats after controllable or uncontrollable tailshock. A series of identical tailshocks were delivered to yoked pairs of rats. One rat could terminate shocks to both rats of the pair. Reductions in neural progenitor cells were observed at 1-2 days and at 28 days in rats exposed to uncontrollable shock. Controllable shock produced an increase in fibroblast growth factor-2 in the dentate gyrus and CAI 2 h after stress and in the dentate gyrus 24 h after stress. Thus, stressor controllability modulates stress-induced decreases in neurogenesis and increases in fibroblast growth factor-2. (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:593 / 597
页数:5
相关论文
共 50 条
  • [41] Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation
    Sahni, A
    Baker, CA
    Sporn, LA
    Francis, CW
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (05) : 736 - 741
  • [42] TRX is up-regulated by fibroblast growth factor-2 in lung carcinoma
    Deng, Zheng-Hao
    Cao, Hui-Qiu
    Hu, Yong-Bin
    Wen, Ji-Fang
    Zhou, Jian-Hua
    APMIS, 2011, 119 (01) : 57 - 65
  • [43] Topical fibroblast growth factor-2 for treatment of chronic tympanic membrane perforations
    Santos, Felipe
    Shu, Edina
    Lee, Daniel J.
    Jung, David H.
    Quesnel, Alicia
    Stankovic, Konstantina
    Abdul-Aziz, Dunia
    Bay, Camden P.
    Quinkert, Amy
    Welling, D. Bradley
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (04): : 657 - 664
  • [44] Effects of fibroblast growth factor-2 on the in vitro culture of caprine preantral follicles
    Matos, M. H. T.
    van den Hurk, R.
    Lima-Verde, I. B.
    Luque, M. C. A.
    Santos, K. D. B.
    Martins, F. S.
    Bao, S. N.
    Lucci, C. M.
    Figueiredo, J. R.
    CELLS TISSUES ORGANS, 2007, 186 (02) : 112 - 120
  • [45] Regulation of Fibroblast Growth Factor-2 by an Endogenous Antisense RNA and by Argonaute-2
    MacFarlane, Leigh-Ann
    Gu, Ying
    Casson, Alan G.
    Murphy, Paul R.
    MOLECULAR ENDOCRINOLOGY, 2010, 24 (04) : 800 - 812
  • [46] Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells
    Tsunematsu, Hinako
    Tatsumi, Tomohide
    Kohga, Keisuke
    Yamamoto, Masashi
    Aketa, Hiroshi
    Miyagi, Takuya
    Hosui, Atsushi
    Hiramatsu, Naoki
    Kanto, Tatsuya
    Hayashi, Norio
    Takehara, Tetsuo
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (02) : 356 - 364
  • [47] Differential expression of basic fibroblast growth factor-2 in the developing rat brain
    Monfils, M. -H.
    Driscoll, I.
    Melvin, N. R.
    Kolb, B.
    NEUROSCIENCE, 2006, 141 (01) : 213 - 221
  • [48] Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures
    Spuch, Carlos
    Diz-Chaves, Yolanda
    Perez-Tilve, Diego
    Mallo, Federico
    ENDOCRINE, 2006, 29 (02) : 317 - 324
  • [49] Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures
    Carlos Spuch
    Yolanda Diz-Chaves
    Diego Pérez-Tilve
    Federico Mallo
    Endocrine, 2006, 29 : 317 - 324
  • [50] Selection and characterization of a human neutralizing antibody to human fibroblast growth factor-2
    Tao, Jun
    Xiang, Jun-Jian
    Li, Dan
    Deng, Ning
    Wang, Hong
    Gong, Yi-Ping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (03) : 767 - 773